Veranova to expand ADCs and high potency site

Veranova has initiated a “significant” expansion of its ADC and highly potent compound development and manufacturing capabilities at Devens, Massachusetts, at a cost of about $30 million. The company said that this will address growing demand for strong US-based capacity for ADCs and other potent small molecules.

The expansion will include a new high potent process development laboratory and two new cGMP suites designed to handle potent compounds with OELs of <0.01 µg/m³. These will feature dedicated air handling systems, airlocks for clean-in-place operations, isolator technology and processing capabilities, including synthesis reactors, chromatography, thin film evaporators and lyophilisation.